By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PTC Therapeutics, Inc. 

100 Corporate Court

South Plainfield  New Jersey  07080-2449  U.S.A.
Phone: 908-222-7000 Fax: 908-222-7231


Drug Discovery

Company News
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 9/13/2016 6:56:04 AM
PTC Therapeutics (PTCT) Recognizes World Duchenne Awareness Day By Announcing Winners Of Global Duchenne Muscular Dystrophy Patient Group Awards And Expanding Disease State Awareness Website 9/7/2016 10:53:27 AM
PTC Therapeutics (PTCT) Reports Second Quarter 2016 Financial Results And Provides Corporate Update 8/5/2016 8:22:13 AM
PTC Therapeutics (PTCT) Provides Regulatory Update On Translarna (Ataluren) 7/25/2016 10:17:27 AM
PTC Therapeutics (PTCT) To Host Conference Call To Discuss Second Quarter Financial Results 7/21/2016 7:20:14 AM
In Conversation With Paul Martin, Lorraine Bracy And Natalie Bilci Of PTC Therapeutics (PTCT) Legal Department 6/22/2016 2:51:21 PM
PTC Therapeutics (PTCT) Appoints Dawn Svoronos To Board Of Directors 6/14/2016 11:18:36 AM
PTC Therapeutics (PTCT) Release: New Analyses From Phase 3 Study 009 Of Translarna (Ataluren) In Patients With Cystic Fibrosis Presented At 39th European Cystic Fibrosis Conference 6/10/2016 9:34:22 AM
PTC Therapeutics (PTCT) Announces Winners Of The Global Cystic Fibrosis Patient Group Awards 5/16/2016 8:26:10 AM
PTC Therapeutics (PTCT) Reports First Quarter 2016 Financial Results And Provides Corporate Update 5/6/2016 6:25:05 AM